Home Oculex

Oculex

acquired
Series B
Ophthalmic Drug Delivery Product Developer

Basic Information

Oculex Pharmaceuticals is an ophthalmic drug delivery company focused on developing therapeutic products for the treatment of vision-threatening diseases. Oculex Pharmaceuticals has developed Posurdex, a biodegradable sustained-release implant that delivers dexamethasone to targeted disease sites in the posterior segment of the eye.
Oculex Pharmaceuticals, Inc.
California,United States of America
101~500 people
June 30, 1989
--
--